The weight of evidence supports a role in dementia risk reduction, particularly among individuals with diabetes, obesity, metabolic syndrome, or APOE 4 risk
Holman RR, Bethel MA, Mentz RJ et al (2017) Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes
Frequently Asked Questions Are compounded GLP-1 medications safe
Some insured patients report copays as low as $25, depending on coverage details
In the future, similar trials for the treatment of OSA such as new GLP-1 RA semaglutide versus liraglutide, directly or in combination with CPAP versus CPAP alone, could be conducted to provide recommendations for whether and which GLP-1 RA to use in the clinic
Early studies indicate growth (or slower decline) in volume for protein-forward products like some dairy products that appear to be less affected